Literature DB >> 19031966

Fatal thrombocytopenia after oxaliplatin-based chemotherapy.

Yu-Yun Shao1, Ruey-Long Hong.   

Abstract

Oxaliplatin-related thrombocytopenia is considered rare and mostly self-limited. We present the first reported fatal case due to this complication. A 64-year-old patient with metastatic colon cancer was admitted for his 24th course of chemotherapy with oxaliplatin and 24-hour infusion of fluorouracil and leucovorin. Consciousness changed on the next evening and deteriorated to deep coma within hours. Computed tomography revealed large intracranial hemorrhage with brain herniation. Hemogram showed severe thrombocytopenia, which was considered to be associated with oxaliplatin. The patient died six days later. The incidence of oxaliplatin-related thrombocytopenia may have been underestimated and its severity long neglected. Other hypersensitivity reactions may precede its onset. Early hemogram examination during hypersensitivity reaction to oxaliplatin may provide early diagnosis and the prevention of the possible fatal consequences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031966

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Authors:  Marnelli A Bautista; W Tait Stevens; Chien-Shing Chen; Brian R Curtis; Richard H Aster; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-03-26       Impact factor: 17.388

2.  Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: A review of two cases.

Authors:  Mila Bouchereau; Mai-Kim Gervais; Lucas Sideris; Marie-Hélène Loriot; Stéphane P Ahern; Pierre Dubé
Journal:  J Gastrointest Oncol       Date:  2011-06

3.  Oxaliplatin-induced acute-onset thrombocytopenia and hemorrhage: Case report and review of the literature.

Authors:  Shoichiro Ohta; Yukiko Cho; Shinji Oshima; Osamu Hosoya; Kazuhiko Juni; Hiroshi Kojima
Journal:  Oncol Lett       Date:  2012-03-23       Impact factor: 2.967

4.  Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis.

Authors:  Min Li; Chen Jiang; Jing-Wen Yang; Zao-Qin Yu; Wei Li; Li Zhao; Qiu-Yan Song; Cheng-Liang Zhang; Dong Liu
Journal:  Curr Med Sci       Date:  2021-08-17

5.  Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literature.

Authors:  Shweta Kurian; Jessica Macintyre; Muzammil Mushtaq; Caio Max Rocha-Lima; Yeon Ahn
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

Review 6.  Severe Thrombocytopenia Associated With Pembrolizumab in Patients With Non-small Cell Lung Cancer (NSCLC): A Case Report and Literature Review.

Authors:  Atsuto Mouri; Kyoichi Kaira; Ayako Shiono; Y U Miura; Hiroshi Kagamu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 7.  Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.

Authors:  Jui-Ho Wang; Tai-Ming King; Min-Chi Chang; Chao-Wen Hsu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

8.  Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia.

Authors:  Kriti Mittal; Michael J McNamara; Brian R Curtis; Keith R McCrae
Journal:  JRSM Open       Date:  2014-05-06

9.  Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.

Authors:  Eric L Tam; Padma L Draksharam; Jennifer A Park; Gurinder S Sidhu
Journal:  Case Rep Oncol Med       Date:  2019-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.